Ionis Pharmaceuticals Shares Drop Over 40% Despite Wall Street's Bullish Outlook

Ionis Pharmaceuticals' stock has fallen by more than 40% this year, indicating significant investor sell-off. However, Wall Street analysts remain optimistic about the company's prospects, maintaining a bullish stance despite the decline.

Originally published by gnews